Effects of Leptin Replacement in Children

Key facts

Sponsor

University of Miami

Principal Investigator

Julio Licinio, MD

University of Miami

Intervention

Recombinant methionyl human leptin(drug)

Enrollment

1 enrolled

Eligibility

5-18 years · MALE

Timeline

2005 – 2010

Study locations (1)

• University of Miami, Center on Pharmacogenomics, Miami, Florida, United States

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Neonatal diabetes mellitus

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07442682
  Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center
  Erasme University Hospital
• RECRUITINGNCT06407388
  Ultrasound Findings in Diabetic Pregnancies
  Eastern Virginia Medical School

See all trials for Neonatal diabetes mellitus →